| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/27/2004 | WO2003006034A3 Herbal formulation |
| 05/27/2004 | WO2003006033A3 Herbal formulation |
| 05/27/2004 | WO2003006002A8 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 05/27/2004 | WO2003004604A3 Phage displayed pdz domain ligands |
| 05/27/2004 | WO2003003985A3 Polyvalent conjugate vaccine for cancer |
| 05/27/2004 | WO2002102854A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | WO2002081462A8 Aminoflavone compounds, compositions, and methods of use thereof |
| 05/27/2004 | WO2002057284A8 New inhibitors against galectins |
| 05/27/2004 | WO2000073764A3 Composition and methods for the therapeutic use of an atonal-associated sequence |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102626 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use cardiovascular preparations |
| 05/27/2004 | US20040102615 Method for isolating and purifying a protein and resulting protein |
| 05/27/2004 | US20040102607 Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 05/27/2004 | US20040102526 Use of aloe-emodin in the treatment of neuroectodermal tumors |
| 05/27/2004 | US20040102510 Cancer; the compounds interact with the amino acids in the catalytic region of PKs and bind in the general space normally occupied by the adenine ring of ATP |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102497 Novel inhibitors of IMPDH enzyme |
| 05/27/2004 | US20040102492 Inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds. Ar1 is carbocycle optionally substituted with one R1, and wherein Ar1 |
| 05/27/2004 | US20040102479 Novel benzopyran or thiobenzopyran derivatives |
| 05/27/2004 | US20040102471 Viricides; anticancer agents |
| 05/27/2004 | US20040102467 Antiinflammatory agents; central nervous system disorders; antiproliferative agents |
| 05/27/2004 | US20040102464 Hypotensive agents; cardiovascular disorders; anticancer agents; headaches; antihistamines; antiinflamamtory agents |
| 05/27/2004 | US20040102461 Synergistic mixture with anticancer drugs |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102458 Antiproliferative agents; antitumor agents; binding to chaperone protein |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102453 Antiproliferative agents |
| 05/27/2004 | US20040102452 Antiproliferative agents; anticancer agents; antiinflammatroy agents; Alzheimer's disease; viricides; fungicides |
| 05/27/2004 | US20040102451 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 05/27/2004 | US20040102450 Substituted oxoazaheterocyclyl compounds |
| 05/27/2004 | US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/27/2004 | US20040102447 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 05/27/2004 | US20040102443 Nitro and amino substituted topoisomerase agents |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102438 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 05/27/2004 | US20040102435 Alzheimer's disease; psychological disorders; anxiolytic agents; antidepressants; hormone replacement therapy |
| 05/27/2004 | US20040102430 Drug delivery systems for photodynamic therapy |
| 05/27/2004 | US20040102428 Chemokine receptor binding heterocyclic compounds |
| 05/27/2004 | US20040102422 Administering human papillomaviruse protein; urogenital cancer therapy |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102410 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 05/27/2004 | US20040102408 Method and medicament for inhibiting the expression of a given gene |
| 05/27/2004 | US20040102407 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 05/27/2004 | US20040102406 Phosphorothioate oligonucleotides directed to a subunit of an integrin vitronectin receptor to inhibit angiogenesis and/or metastasis |
| 05/27/2004 | US20040102383 Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy |
| 05/27/2004 | US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 05/27/2004 | US20040102376 Use of rgm and its modulators |
| 05/27/2004 | US20040102372 Therapeutic antiangiogenic compositions and methods |
| 05/27/2004 | US20040101931 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 05/27/2004 | US20040101915 Diagnosis and treatment of chemoresistant tumors |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101875 Novel g protein-coupled receptor protein and dna thereof |
| 05/27/2004 | US20040101593 Preventives or remedies for tumor of human papillomaviral disease |
| 05/27/2004 | US20040101580 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 05/27/2004 | US20040101574 Antitumor |
| 05/27/2004 | US20040101562 Enzyme encapsulated in hydrophilic low melting polymer; bioavailability |
| 05/27/2004 | US20040101533 Fusion protein; antitumor, anticancer agenst |
| 05/27/2004 | US20040101529 Regulation of human serine-threonine protein kinase |
| 05/27/2004 | US20040101511 Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
| 05/27/2004 | CA2545930A1 Tumour marker proteins and uses thereof |
| 05/27/2004 | CA2506091A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface |
| 05/27/2004 | CA2505819A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | CA2505036A1 4-amino-5-phenyl-7-cyclohexyl-pyrrolo¬2,3-d|pyrimidine derivatives |
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | CA2504666A1 Combination product of inhibitor of the src family of non-receptor tyrosine kinases and gemcitabine |
| 05/27/2004 | CA2503995A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 05/27/2004 | CA2503992A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/27/2004 | CA2502890A1 Treating carcinoid neoplasms with therapeutic viruses |
| 05/27/2004 | CA2502190A1 Pyrimidine compounds |
| 05/27/2004 | CA2501932A1 Use of benzimidazole quinolinones for treating cancer |
| 05/27/2004 | CA2497268A1 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/26/2004 | EP1422524A1 Screening method |
| 05/26/2004 | EP1422243A1 HUMANIZED ANTIBODY AGAINST FIBROBLAST GROWTH FACTOR−8 AND FRAGMENT OF THE ANTIBODY |
| 05/26/2004 | EP1422225A1 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use |
| 05/26/2004 | EP1422224A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 05/26/2004 | EP1421956A1 Process for stepwise attachment of polyethylene glycol (PEG) to a polypeptide |
| 05/26/2004 | EP1421947A1 p53 vaccine |
| 05/26/2004 | EP1421945A1 Bile acid absorbent/adsorbent |
| 05/26/2004 | EP1421942A1 Use of glycyrrhizin and its derivatives as RANTES inducers |
| 05/26/2004 | EP1421938A1 Antitumor agents and process for producing the same |
| 05/26/2004 | EP1421937A1 Use of amino acids for making medicines for treating insulin-resistance |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421384A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421214A2 Amplified oncogenes and their involvement in cancer |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421113A1 Methods of screening based on the egf receptor crystal structure |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421107A1 Peptides having antiangiogenic activity |
| 05/26/2004 | EP1421105A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 05/26/2004 | EP1421101A2 P-glycoproteins and uses thereof |
| 05/26/2004 | EP1421099A1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 05/26/2004 | EP1421084A1 Polycyclic guanine phosphodiesterase v inhibitors |